{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:24:15Z","timestamp":1777681455680,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Sexually transmitted infections are a prevalent global health care problem. Treatment guidelines have recently been updated as a result of antimicrobial resistance and public health trends. The aim of the study was to assess the appropriateness of empirical antibiotic therapy prescribed for cervicitis and urethritis in the emergency department.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We designed a retrospective observational cohort study. We included adult patients with suspected cervicitis or urethritis who attended the emergency department of a tertiary hospital in 2020. We excluded patients with suspected pelvic inflammatory disease, pregnancy or prostatitis and those requiring admission to hospital. Appropriateness of empirical antibiotic therapy was evaluated taking into account 4 aspects: indication, dosing, duration of therapy, and route of administration. Data were obtained from the electronic medical record, the electronic prescription program, and the discharge summary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study population comprised 176 patients; mean age was 28.9\u2009years (SD\u2009=\u20097.7), and 90.9% were men. The most prescribed treatment was the combination of ceftriaxone and azithromycin (83.0%). Treatment was inappropriate in 71.6% of patients. A total of 159 drug errors were recorded. The most frequent cause was undertreatment (36.4%) related to underdosing (46.5%), particularly with regard to ceftriaxone. The percentage of errors was 11.9% for indication, 84.9% for dosing, 3.1% for duration, and 0% for route of administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A high percentage of patients who attended the emergency department for suspected cervicitis or urethritis received an inappropriate empirical antibiotic regimen. The main reason was undertreatment due to underdosing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00185787221123219","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T02:01:45Z","timestamp":1662775305000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department"],"prefix":"10.1177","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-1205","authenticated-orcid":false,"given":"Ana","family":"de Lorenzo-Pinto","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ortega-Navarro","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Torroba-Sanz","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia M.","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Taladriz-Sender","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Castuera-Gil","sequence":"additional","affiliation":[{"name":"Emergency Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"A. Andueza Lillo","sequence":"additional","affiliation":[{"name":"Emergency Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Sanjurjo-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"bibr1-00185787221123219","unstructured":"World Health Organization. Report on Global Sexually Transmitted Infection Surveillance, 2018. World Health Organization; 2018. Accessed January 3, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789241565691"},{"key":"bibr2-00185787221123219","unstructured":"Centers for Disease Control and Prevention. Diseases characterized by urethritis and cervicitis; 2021. Accessed February 4, 2022.\u2009https:\/\/www.cdc.gov\/std\/treatment-guidelines\/urethritis-and-cervicitis.htm"},{"key":"bibr3-00185787221123219","first-page":"1","volume":"59","author":"Workowski KA","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"bibr4-00185787221123219","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018: Gonococcal Isolate Surveillance Project (GISP) Supplement and Profiles. U.S. Department of Health and Human Services; 2020. Accessed January 2, 2022. https:\/\/www.cdc.gov\/std\/stats18\/gisp2018\/docs\/gisp_2018_supplement_final_2020.pdf"},{"key":"bibr5-00185787221123219","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"bibr6-00185787221123219","doi-asserted-by":"publisher","DOI":"10.1177\/0956462420949126"},{"key":"bibr7-00185787221123219","doi-asserted-by":"publisher","DOI":"10.1177\/0956462415618837"},{"key":"bibr8-00185787221123219","unstructured":"Madrid Healthcare System. Guidelines for the Use of Antimicrobial Therapy in Outpatients. Madrid Healthcare System; December 2021. Accessed January 8, 2022. http:\/\/www.madrid.org\/bvirtual\/BVCM050515.pdf"},{"key":"bibr9-00185787221123219","unstructured":"Spanish Agency of Medicines and Medical Devices. Ceftriaxona 250 mg intramuscular. 2022. Accessed January 8, 2022. https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/62639\/FT_62639.pdf"},{"key":"bibr10-00185787221123219","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2004.tb01455.x"},{"key":"bibr11-00185787221123219","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.1042"},{"key":"bibr12-00185787221123219","unstructured":"European Centre for Disease Prevention and Control. Strategies and Action Plans on Antimicrobial Resistance. European Centre for Disease Prevention and Control. Accessed March 5, 2022. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/directory-guidance-prevention-and-control\/antimicrobial-resistance-strategies"},{"key":"bibr13-00185787221123219","volume-title":"To Err is Human: Building a Safer Health System","author":"Institute of Medicine","year":"1999"},{"key":"bibr14-00185787221123219","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787221123219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787221123219","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787221123219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:39:57Z","timestamp":1777451997000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787221123219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1177\/00185787221123219"],"URL":"https:\/\/doi.org\/10.1177\/00185787221123219","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}